Rydex NASDAQ-100 2x Strategy Fund
RYCCX News Today: Stay Updated with the Latest Rydex NASDAQ-100 2x Strategy Fund News in Real Time
Find RYCCX news now at Meyka AI. Stay informed with the latest Rydex NASDAQ-100 2x Strategy Fund stocks updates, including price news, market analysis, and expert insights.
MMSI Insider Buying: CFO Raul Parra Acquires 1,500 Shares May 08, 2026
Merit Medical Systems CFO Raul Parra Jr. purchases 1,500 shares at $61.01 on May 6, 2026. Insider buying signal for MMSI stock.
TEL Officer Kroeger Acquires 9,400 Shares on May 06, 2026
TE Connectivity officer Shadrak Kroeger acquired 9,400 shares at $93.63 on May 6, 2026. Insider buying signal for TEL stock.
ADXN.SW stock drops 6.25% on May 8, 2026 amid biotech weakness
ADXN.SW stock falls 6.25% to CHF0.045 on SIX. Addex Therapeutics faces headwinds with C- rating and negative cash flow metrics.
T6ET.DE Stock Sees 2,246 Volume Spike on XETRA Today
T6ET.DE stock trading at €26.37 on XETRA with 2,246 volume spike. VanEck Global Equal Weight ETF analysis and market activity.
8012.T Nagase & Co. Earnings Beat Revenue Estimate
Nagase & Co. (8012.T) beat revenue estimates with $248.75B actual vs $240.93B forecast, up 3.25% in May 2026 earnings.
Sony Predicts Increased Gaming Profits Despite Declining Sales as Memory Costs Rise
Sony is entering a very interesting phase in its gaming business. The company expects stronger gaming profits ahead, even though hardware sales are slowing down. This situation may look confusing at first, but it reflects a deeper shift in how Sony earns money from PlayStation. We from the market side can clearly see a pattern….
RDNT RadNet Earnings Preview May 10, 2026
RadNet earnings preview: EPS estimate -$0.16, revenue $557.93M expected May 10. Analyst consensus and what to watch.
YAYO Stock Crashes 99.75% on May 8, 2026 – EVmo Inc. Plummets
YAYO stock plunges 99.75% to $0.0001 on May 8, 2026. EVmo Inc. faces severe losses with negative cash flow and mounting debt.
PVCT CEO Pershing Acquires 18,876 Shares on May 08, 2026
PVCT CEO Edward Pershing acquires 18,876 Series D-1 preferred shares. Insider buying signals confidence in Provectus Biopharmaceuticals.